NEUROCRINE BIOSCIENCES
Live / Registered — Registered (as of 22 Apr 2025)
What this means for you
Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90981369
- Registration number
- 7770329
- Mark type
- Design + words
- Filed
- 16 Aug 2021
- Published for opposition
- 13 Dec 2022
- Registered
- 22 Apr 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for treatment of neuroendocrinological diseases, disorders, and conditions; Pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
- Class 044 — Medical, beauty and agricultural services: providing medical information in the field of hormonal and genetic diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of hormonal and genetic diseases, disorders and conditions
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Feb 2025 — USE AMENDMENT FILED
- 26 Feb 2025 — DIVISIONAL PROCESSING COMPLETE
- 06 Feb 2025 — DIVISIONAL REQUEST RECEIVED
- 06 Feb 2025 — TEAS REQUEST TO DIVIDE RECEIVED